Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: Podcast

Halteres Associates Launches Halteres Presents Podcast Series


Halteres Associates, a leading bioscience consultancy that provides strategic and tactical services in the areas of diagnostics, medical devices, and life science research to clients of all sizes, today has launched season one of their new podcast series, Halteres Presents. The series, co-hosted by Halteres Associates partners Rich Thayer and Mickey Urdea, is described as a brand-agnostic interview podcast that seeks to provide an impartial perspective on the latest developments in medical diagnostics.

Selections from the upcoming season of Halteres Presents include:

"We noticed a lack of opportunities within the diagnostics media landscape for prominent individuals to exchange knowledge directly with their colleagues, beyond traditional journals and conferences, or for other listeners to enrich their understanding of key issues influencing the availability of new testing solutions," stated Halteres managing partner Rich Thayer. "We wanted to create our own sandbox where experts could come share their insights, experiences, forecasts, and observations beyond simply a high-level overview."

Founding partner Mickey Urdea added that the aim of the podcast is to provide a platform for guests to share their extensive experience and insights, with the ultimate goal of driving the conversation around diagnostics forward for both experts and novices. "By codifying these lessons learned, we're helping others to avoid the same pitfalls in their own journeys," said Urdea. "As the Roman saying goes: ?A wise man learns from the mistakes of others; a fool learns from his own.'"

New episodes of season one of Halteres Presents will be released weekly on Apple and Spotify. Season two is already in the works and is set to be released later in 2023.

Apple Podcasts Link: https://podcasts.apple.com/us/podcast/halteres-presents/id1675559229

Spotify Link: https://open.spotify.com/show/436uwcDjTxAlOIiVXsGUDJ?si=6f71d5d23e0b4fd4

About Halteres Associates

Founded in 2002, San Ramon-based Halteres Associates, LLC, provides strategic and tactical consulting services to organizations in the areas of diagnostics, global health, medical devices, and life science research. With decades of combined experience and leveraging a robust network of industry professionals across multiple disciplines, Halteres Associates assists organizations with technology creation and applications, product and market development, opportunity and economic analyses, business modeling, and more. Their clients include large multinational companies, global nongovernmental organizations, and emerging industry innovators.


These press releases may also interest you

at 21:41
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and other major...

at 21:30
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:19
China Medical University Hospital (CMUH, Taiwan) and the Malaysian International Medical University (IMU), the first and top private medical and health science university in Malaysia, jointly signed a memorandum of understanding (MOU) on...

at 21:14
Keymed Biosciences Inc. (HKEX: 02162) today announced the long-term efficacy and safety data of a Phase III clinical trial of stapokibart injection in patients with moderate-to-severe atopic dermatitis (AD) has been released by way of oral...

at 21:11
Telix Pharmaceuticals Limited today announces that it has completed the submission of a Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for its investigational radiodiagnostic PET[1] agent,...

at 18:05
A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, London, used an ultra-sensitive liquid biopsy to...



News published on and distributed by: